Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,095Revenue $M297Net Margin (%)-21.5Altman Z-Score3.6
Enterprise Value $M5,121EPS $-3.2Operating Margin %-1.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-22.3Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales9.15-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-8.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-24.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)8.3Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 32.9880%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 32.98164%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 32.98186%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 32.98131%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Himawan JeffDirector 2015-03-13Sell554,564$22.4446.97view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.8550.94view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.05173.69view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.05173.69view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.05173.69view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.54185.79view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.54185.79view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.54185.79view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$0185.79view
DE VAERE ROBERT JEVP & CFO 2014-09-30Sell51,942$12.28168.57view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Horizon Pharma plc Files Patent Infringement Lawsuits Against Five Companies for Filing Abbreviated Jul 06 2015 
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice o Jul 02 2015 
hznp May 24 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 
Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015 Jan 28 2015 
Horizon Pharma plc Provides Business Update Jan 12 2015 
Horizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an Dec 24 2014 
Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014 
Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholder Nov 14 2014 

More From Other Websites
Horizon Pharma Goes Hostile In Depomed Bid Jul 07 2015
U.S. stocks close higher as Greece debt talks proceed Jul 07 2015
HORIZON PHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 07 2015
Horizon Pharma at the Nexus of Taxes and Deals Jul 07 2015
Mid-Afternoon Market Update: A Schulman Slips After Q3 Results; Plug Power Shares Spike Higher Jul 07 2015
US stocks head higher as Greece debt talks proceed Jul 07 2015
US stocks head lower as Greece debt talks resume Jul 07 2015
US stocks head lower as Greece debt talks resume Jul 07 2015
US STOCKS-Wall St lower on China concerns; Greece watched Jul 07 2015
Horizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bid Jul 07 2015
Horizon Pharma PLC -- Moody's: Horizon Pharma's Depomed offer is credit positive Jul 07 2015
DEPO: Horizon / Depomed Combination Makes Strategic Sense, But Offer Too Low Jul 07 2015
Horizon Pharma goes hostile with $3 billion offer for Depomed Jul 07 2015
US stocks heads lower as Greece debt talks proceed Jul 07 2015
US stocks heads lower as Greece debt talks proceed Jul 07 2015
Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed Jul 07 2015
Depomed rejects third buyout offer from Horizon Jul 07 2015
Trending Now: Horizon Pharma Jul 07 2015
Horizon Pharma Makes Hostile Bid to Acquire DepoMed Jul 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK